Published, Version of Record (VoR)CC BY-NC V4.0, Open
Abstract
General & Internal Medicine Life Sciences & Biomedicine Medicine, General & Internal Science & Technology
Endocrinopathies following immunotherapy have infrequently been documented in the literature. Adrenal insufficiency is a rare consequence of pembrolizumab immunotherapy, with incidence reported to be between 0.98 and 1.3%. We present the case of a 34-year-old female with triple negative breast cancer on chemotherapy who presented with generalized weakness with tachycardia, tachypnea and hypotension unresponsive to fluids. Despite initial improvement with intravenous hydrocortisone and midodrine, the patient continued to be symptomatically hypotensive following discharge and required re-admission. AM cortisol level was found to be < 0.5 ug/dl and ACTH was < 1.5 pg/dL, consistent with secondary adrenal insufficiency. CT abdomen and pelvis was unremarkable for adrenal pathology. Patient had been initiated on pembrolizumab (Keytruda) 4 months prior to presentation as part of neoadjuvant chemotherapy. The patient was provided supportive treatment with discharge on fludrocortisone, prednisone, and midodrine. This case reports an unusual consequence of immune checkpoint inhibitors, in which early diagnostic testing, identification, and management is critical.
Metrics
11 Record Views
Details
Title
Immunotherapy Induced Adrenal Insufficiency: An Underdiagnosed Cause of Persistent Hypotension in Cancer
Creators
Nina H. Cheng - Drexel University
Hannah Lee - Drexel University
Divya Balchander - St. Vincent's Medical Center
Remy Mimms - University of California, Irvine
Mahesh Krishnamurthy - St. Luke's Hospital
Publication Details
Journal of community hospital internal medicine perspectives, v 14(4), pp 68-70
Publisher
DIGITAL COMMONS BEPRESS
Number of pages
4
Resource Type
Journal article
Language
English
Academic Unit
Medicine (Graduate)
Web of Science ID
WOS:001263086800018
Other Identifier
991021932789604721
UN Sustainable Development Goals (SDGs)
This publication has contributed to the advancement of the following goals:
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool:
Collaboration types
Domestic collaboration
Web of Science research areas
Oncology
Research Home Page
Browse by research and academic units
Learn about the ETD submission process at Drexel
Learn about the Libraries’ research data management services